|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003209,
umls-concept:C0010068,
umls-concept:C0014257,
umls-concept:C0030705,
umls-concept:C0441712,
umls-concept:C0542341,
umls-concept:C1154253,
umls-concept:C1555707,
umls-concept:C1566069,
umls-concept:C1705851,
umls-concept:C2752151,
umls-concept:C2828366
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2004-8-24
|
|
pubmed:abstractText |
Endothelial dysfunction is associated with inflammation and postprandial hypertriglyceridemia. Xuezhikang, an extract of Cholestin, a dietary supplement, has lipid-modulating and antiinflammatory effects. We explored the effects of xuezhikang on endothelial function and high-sensitivity C-reactive protein (hs-CRP) in patients with coronary heart disease (CHD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Cardiovascular Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Dietary Fats,
http://linkedlifedata.com/resource/pubmed/chemical/Drugs, Chinese Herbal,
http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides,
http://linkedlifedata.com/resource/pubmed/chemical/red yeast rice
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
24
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
915-20
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15313947-Angina Pectoris,
pubmed-meshheading:15313947-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:15313947-Biological Agents,
pubmed-meshheading:15313947-Biological Markers,
pubmed-meshheading:15313947-Brachial Artery,
pubmed-meshheading:15313947-C-Reactive Protein,
pubmed-meshheading:15313947-Cardiovascular Agents,
pubmed-meshheading:15313947-Dietary Fats,
pubmed-meshheading:15313947-Drugs, Chinese Herbal,
pubmed-meshheading:15313947-Endothelium, Vascular,
pubmed-meshheading:15313947-Fasting,
pubmed-meshheading:15313947-Female,
pubmed-meshheading:15313947-Humans,
pubmed-meshheading:15313947-Hypertriglyceridemia,
pubmed-meshheading:15313947-Hypolipidemic Agents,
pubmed-meshheading:15313947-Male,
pubmed-meshheading:15313947-Middle Aged,
pubmed-meshheading:15313947-Postprandial Period,
pubmed-meshheading:15313947-Prospective Studies,
pubmed-meshheading:15313947-Treatment Outcome,
pubmed-meshheading:15313947-Triglycerides,
pubmed-meshheading:15313947-Vasodilation
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease.
|
|
pubmed:affiliation |
Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, PR China.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
